IVECO GROUP NV (IVG.MI) Stock Fundamental Analysis

BIT:IVG • NL0015000LU4

19.15 EUR
+0.02 (+0.1%)
Last: Feb 27, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to IVG. IVG was compared to 109 industry peers in the Machinery industry. While IVG is still in line with the averages on profitability rating, there are concerns on its financial health. IVG may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • IVG had positive earnings in the past year.
  • IVG had a positive operating cash flow in the past year.
  • Each year in the past 5 years IVG has been profitable.
  • IVG had a positive operating cash flow in each of the past 5 years.
IVG.MI Yearly Net Income VS EBIT VS OCF VS FCFIVG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 1.48%, IVG is doing worse than 63.30% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 10.01%, IVG is in the better half of the industry, outperforming 66.06% of the companies in the same industry.
  • IVG has a worse Return On Invested Capital (4.17%) than 60.55% of its industry peers.
Industry RankSector Rank
ROA 1.48%
ROE 10.01%
ROIC 4.17%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IVG.MI Yearly ROA, ROE, ROICIVG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10

1.3 Margins

  • Looking at the Profit Margin, with a value of 1.82%, IVG is doing worse than 63.30% of the companies in the same industry.
  • IVG's Profit Margin has improved in the last couple of years.
  • IVG has a worse Operating Margin (4.33%) than 61.47% of its industry peers.
  • In the last couple of years the Operating Margin of IVG has grown nicely.
  • With a Gross Margin value of 16.00%, IVG is not doing good in the industry: 91.74% of the companies in the same industry are doing better.
  • IVG's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.33%
PM (TTM) 1.82%
GM 16%
OM growth 3Y5.55%
OM growth 5YN/A
PM growth 3Y27.65%
PM growth 5YN/A
GM growth 3Y3.95%
GM growth 5Y11.26%
IVG.MI Yearly Profit, Operating, Gross MarginsIVG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • IVG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • IVG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IVG.MI Yearly Shares OutstandingIVG.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
IVG.MI Yearly Total Debt VS Total AssetsIVG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • IVG has an Altman-Z score of 1.75. This is a bad value and indicates that IVG is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of IVG (1.75) is comparable to the rest of the industry.
  • The Debt to FCF ratio of IVG is 9.94, which is on the high side as it means it would take IVG, 9.94 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 9.94, IVG is not doing good in the industry: 64.22% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 1.29 is on the high side and indicates that IVG has dependencies on debt financing.
  • With a Debt to Equity ratio value of 1.29, IVG is not doing good in the industry: 83.49% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF 9.94
Altman-Z 1.75
ROIC/WACC0.57
WACC7.3%
IVG.MI Yearly LT Debt VS Equity VS FCFIVG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B 5B

2.3 Liquidity

  • IVG has a Current Ratio of 1.91. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
  • IVG has a Current ratio of 1.91. This is in the better half of the industry: IVG outperforms 67.89% of its industry peers.
  • IVG has a Quick Ratio of 1.38. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of IVG (1.38) is better than 77.98% of its industry peers.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 1.38
IVG.MI Yearly Current Assets VS Current LiabilitesIVG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • IVG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -44.23%.
  • Measured over the past years, IVG shows a very strong growth in Earnings Per Share. The EPS has been growing by 34.20% on average per year.
  • Looking at the last year, IVG shows a decrease in Revenue. The Revenue has decreased by -8.94% in the last year.
  • The Revenue has been growing slightly by 5.22% on average over the past years.
EPS 1Y (TTM)-44.23%
EPS 3Y34.2%
EPS 5YN/A
EPS Q2Q%-36.73%
Revenue 1Y (TTM)-8.94%
Revenue growth 3Y-2.21%
Revenue growth 5Y5.22%
Sales Q2Q%-23.06%

3.2 Future

  • The Earnings Per Share is expected to grow by 39.30% on average over the next years. This is a very strong growth
  • IVG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.30% yearly.
EPS Next Y83.33%
EPS Next 2Y50.33%
EPS Next 3Y39.3%
EPS Next 5YN/A
Revenue Next Year8.41%
Revenue Next 2Y7.34%
Revenue Next 3Y8.3%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IVG.MI Yearly Revenue VS EstimatesIVG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B
IVG.MI Yearly EPS VS EstimatesIVG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 16.51, which indicates a correct valuation of IVG.
  • Based on the Price/Earnings ratio, IVG is valued a bit cheaper than the industry average as 75.23% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 27.10, IVG is valued a bit cheaper.
  • The Price/Forward Earnings ratio is 9.00, which indicates a very decent valuation of IVG.
  • Based on the Price/Forward Earnings ratio, IVG is valued cheaply inside the industry as 91.74% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of IVG to the average of the S&P500 Index (28.06), we can say IVG is valued rather cheaply.
Industry RankSector Rank
PE 16.51
Fwd PE 9
IVG.MI Price Earnings VS Forward Price EarningsIVG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 74.31% of the companies in the same industry are more expensive than IVG, based on the Enterprise Value to EBITDA ratio.
  • 77.06% of the companies in the same industry are more expensive than IVG, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.83
EV/EBITDA 6.43
IVG.MI Per share dataIVG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as IVG's earnings are expected to grow with 39.30% in the coming years.
PEG (NY)0.2
PEG (5Y)N/A
EPS Next 2Y50.33%
EPS Next 3Y39.3%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.73%, IVG has a reasonable but not impressive dividend return.
  • IVG's Dividend Yield is a higher than the industry average which is at 1.42.
  • IVG's Dividend Yield is comparable with the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 1.73%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • IVG pays out 33.46% of its income as dividend. This is a sustainable payout ratio.
DP33.46%
EPS Next 2Y50.33%
EPS Next 3Y39.3%
IVG.MI Yearly Income VS Free CF VS DividendIVG.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M 600M
IVG.MI Dividend Payout.IVG.MI Dividend Payout, showing the Payout Ratio.IVG.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

IVECO GROUP NV

BIT:IVG (2/27/2026, 7:00:00 PM)

19.15

+0.02 (+0.1%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-12
Earnings (Next)05-07
Inst Owners33.94%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap5.19B
Revenue(TTM)13.92B
Net Income(TTM)263.00M
Analysts70.77
Price Target20.11 (5.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.73%
Yearly Dividend0.27
Dividend Growth(5Y)N/A
DP33.46%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-42.41%
Min EPS beat(2)-69.38%
Max EPS beat(2)-15.44%
EPS beat(4)2
Avg EPS beat(4)-3.86%
Min EPS beat(4)-69.38%
Max EPS beat(4)63.53%
EPS beat(8)5
Avg EPS beat(8)11.85%
EPS beat(12)7
Avg EPS beat(12)5.5%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.89%
Min Revenue beat(2)-10.33%
Max Revenue beat(2)8.56%
Revenue beat(4)2
Avg Revenue beat(4)-0.65%
Min Revenue beat(4)-10.33%
Max Revenue beat(4)9.28%
Revenue beat(8)5
Avg Revenue beat(8)0.3%
Revenue beat(12)6
Avg Revenue beat(12)0.64%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-19.08%
EPS NY rev (1m)0%
EPS NY rev (3m)-9.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.88%
Revenue NY rev (1m)-0.82%
Revenue NY rev (3m)-4.26%
Valuation
Industry RankSector Rank
PE 16.51
Fwd PE 9
P/S 0.36
P/FCF 8.83
P/OCF 3.66
P/B 1.98
P/tB 7.98
EV/EBITDA 6.43
EPS(TTM)1.16
EY6.06%
EPS(NY)2.13
Fwd EY11.11%
FCF(TTM)2.17
FCFY11.32%
OCF(TTM)5.23
OCFY27.32%
SpS53.38
BVpS9.69
TBVpS2.4
PEG (NY)0.2
PEG (5Y)N/A
Graham Number15.9
Profitability
Industry RankSector Rank
ROA 1.48%
ROE 10.01%
ROCE 5.15%
ROIC 4.17%
ROICexc 5.08%
ROICexgc 6.33%
OM 4.33%
PM (TTM) 1.82%
GM 16%
FCFM 4.06%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y5.55%
OM growth 5YN/A
PM growth 3Y27.65%
PM growth 5YN/A
GM growth 3Y3.95%
GM growth 5Y11.26%
F-Score6
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF 9.94
Debt/EBITDA 2.49
Cap/Depr 112.3%
Cap/Sales 5.74%
Interest Coverage 250
Cash Conversion 103.8%
Profit Quality 223.57%
Current Ratio 1.91
Quick Ratio 1.38
Altman-Z 1.75
F-Score6
WACC7.3%
ROIC/WACC0.57
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)159.8%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-44.23%
EPS 3Y34.2%
EPS 5YN/A
EPS Q2Q%-36.73%
EPS Next Y83.33%
EPS Next 2Y50.33%
EPS Next 3Y39.3%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.94%
Revenue growth 3Y-2.21%
Revenue growth 5Y5.22%
Sales Q2Q%-23.06%
Revenue Next Year8.41%
Revenue Next 2Y7.34%
Revenue Next 3Y8.3%
Revenue Next 5YN/A
EBIT growth 1Y-33.08%
EBIT growth 3Y3.22%
EBIT growth 5YN/A
EBIT Next Year116.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y93.42%
FCF growth 3Y7.24%
FCF growth 5Y37.52%
OCF growth 1Y12%
OCF growth 3Y-17.96%
OCF growth 5Y6.81%

IVECO GROUP NV / IVG.MI FAQ

Can you provide the ChartMill fundamental rating for IVECO GROUP NV?

ChartMill assigns a fundamental rating of 4 / 10 to IVG.MI.


What is the valuation status for IVG stock?

ChartMill assigns a valuation rating of 7 / 10 to IVECO GROUP NV (IVG.MI). This can be considered as Undervalued.


Can you provide the profitability details for IVECO GROUP NV?

IVECO GROUP NV (IVG.MI) has a profitability rating of 4 / 10.


How financially healthy is IVECO GROUP NV?

The financial health rating of IVECO GROUP NV (IVG.MI) is 3 / 10.


Can you provide the expected EPS growth for IVG stock?

The Earnings per Share (EPS) of IVECO GROUP NV (IVG.MI) is expected to grow by 83.33% in the next year.